ATGAM

This brand name is authorized in Canada, Estonia, Hong Kong, Ireland, Japan, New Zealand, Romania, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug ATGAM contains one active pharmaceutical ingredient (API):

1 Antithymocyte immunoglobulin UNII 475247QF1Z - EQUINE THYMOCYTE IMMUNE GLOBULIN

Antithymocyte immunoglobulin is a selective immunosuppressive agent mostly acting on T lymphocytes. Antithymocyte immunoglobulin is used for the prevention and treatment of graft rejection after solid organ transplantation, usually in combination with other immunosuppressive drugs. Read about Antithymocyte immunoglobulin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ATGAM Concentrate for solution for infusion	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AA03	Antilymphocyte immunoglobulin (horse)	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AA Selective immunosuppressants
Discover more medicines within L04AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02234470
Country: EE	Ravimiamet	Identifier(s): 1717231
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 321506
Country: HK	Department of Health Drug Office	Identifier(s): 20962
Country: JP	医薬品医療機器総合機構	Identifier(s): 63994A8A1028
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 4179
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68563001
Country: SG	Health Sciences Authority	Identifier(s): 01490P
Country: US	FDA, National Drug Code	Identifier(s): 0009-7224
Country: ZA	Health Products Regulatory Authority	Identifier(s): T/30.4/717